EP0815220A4 - Transporteur d'amine humaine - Google Patents

Transporteur d'amine humaine

Info

Publication number
EP0815220A4
EP0815220A4 EP95916097A EP95916097A EP0815220A4 EP 0815220 A4 EP0815220 A4 EP 0815220A4 EP 95916097 A EP95916097 A EP 95916097A EP 95916097 A EP95916097 A EP 95916097A EP 0815220 A4 EP0815220 A4 EP 0815220A4
Authority
EP
European Patent Office
Prior art keywords
human amine
amine carrier
carrier
human
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95916097A
Other languages
German (de)
English (en)
Other versions
EP0815220A1 (fr
Inventor
Yi Li
Liang Cao
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0815220A1 publication Critical patent/EP0815220A1/fr
Publication of EP0815220A4 publication Critical patent/EP0815220A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP95916097A 1995-03-01 1995-03-01 Transporteur d'amine humaine Withdrawn EP0815220A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/002645 WO1996027009A1 (fr) 1995-03-01 1995-03-01 Transporteur d'amine humaine

Publications (2)

Publication Number Publication Date
EP0815220A1 EP0815220A1 (fr) 1998-01-07
EP0815220A4 true EP0815220A4 (fr) 2000-10-11

Family

ID=22248753

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95916097A Withdrawn EP0815220A4 (fr) 1995-03-01 1995-03-01 Transporteur d'amine humaine

Country Status (4)

Country Link
EP (1) EP0815220A4 (fr)
JP (1) JPH11506309A (fr)
AU (1) AU2271995A (fr)
WO (1) WO1996027009A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920074D0 (en) * 1999-08-24 1999-10-27 Babraham Inst Animal model and uses thereof
EP2316848A1 (fr) * 1999-09-21 2011-05-04 Chugai Seiyaku Kabushiki Kaisha Gènes transporteurs OATP-B, C, D et E

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025699A1 (fr) * 1992-06-11 1993-12-23 The Regents Of The University Of California Proteines de transport a travers la membrane de vesicules
WO1994016718A1 (fr) * 1991-07-08 1994-08-04 Neurospheres Ltd. Modification genetique de cellules souches nerveuses

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016718A1 (fr) * 1991-07-08 1994-08-04 Neurospheres Ltd. Modification genetique de cellules souches nerveuses
WO1993025699A1 (fr) * 1992-06-11 1993-12-23 The Regents Of The University Of California Proteines de transport a travers la membrane de vesicules

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ERICKSON JEFFREY D ET AL: "Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1996, vol. 93, no. 10, 1996, pages 5166 - 5171, XP002143793, ISSN: 0027-8424 *
ERICKSON JEFFREY D ET AL: "Functional identification and molecular cloning of a human brain vesicle monoamine transporter.", JOURNAL OF NEUROCHEMISTRY, vol. 61, no. 6, 1993, pages 2314 - 2317, XP000916925, ISSN: 0022-3042 *
See also references of WO9627009A1 *
WEIHE EBERHARD ET AL: "Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.", JOURNAL OF MOLECULAR NEUROSCIENCE, vol. 5, no. 3, 1994, pages 149 - 164, XP000916930, ISSN: 0895-8696 *

Also Published As

Publication number Publication date
AU2271995A (en) 1996-09-18
JPH11506309A (ja) 1999-06-08
WO1996027009A1 (fr) 1996-09-06
EP0815220A1 (fr) 1998-01-07

Similar Documents

Publication Publication Date Title
EP0736303A3 (fr) Solution d'interféron
IT9021958A0 (it) Procedimento di purificazione dell'ammoniaca
NO960353L (no) 4-aminobenzoylguanidinderivater
FR2733604B1 (fr) Dispositif d'eclairement
DE59603147D1 (de) Trägeranordnung
NO960392D0 (no) 4-merkaptobenzoylguanidinderivater
KR970027379U (ko) 루퍼롤의 스트립 사향방지장치
FR2733382B1 (fr) Dissimulateur d'enceintes
FR2735986B3 (fr) Prolongateur d'haltere
EP0815199A4 (fr) Desoxycytidine kinase 2 humaine
KR960030674U (ko) V벨트 착탈구
KR960030163U (ko) 혁대
EP0804226A4 (fr) Choline-acetylase humaine
FR2736832B1 (fr) Agent potentialisateur de l'interferon-gamma
UA10890A (uk) Мікроіh'єктор
KR970019493U (ko) 브이씨알의 케이스
KR970026658U (ko) 버클
KR970020537U (ko) 버클
KR970003479U (ko) 탈착이 용이한 무선호출기용 벨트 클립
KR960031955U (ko) 직선형 벨트
KR960033332U (ko) 허리벨트용 클립
KR970038825U (ko) 운반용 기구
KR960030160U (ko) 혁대
KR960030161U (ko) 혁대
KR960036349U (ko) 벨트

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971001

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/12 A, 7A 61K 31/70 B, 7C 07K 14/47 B

A4 Supplementary search report drawn up and despatched

Effective date: 20000822

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030429

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20031208